|
Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Tern company FundamentalVR wins contract from pharmaceutical group
StockMarketWire.com
|
Internet of things investor Tern welcomed news that portfolio company FundamentalVR had won a further £0.4 million contract with 'one of the world's leading pharmaceutical companies'.
The contract, won from an existing client, involved support training and adoption of its Ocular Gene Therapy product.
It covered ongoing repeat licences and support to continue the global rollout of the client's virtual reality training solution, built by FundamentalVR.
Story provided by StockMarketWire.com
|
|
|
|
|